A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

Hydrogels could revolutionize cancer treatment by facilitating targeted drug delivery, reducing adverse effects, and ...

Yahoo Finance anchor Julie Hyman examines some of the top headlines on Wall Street on Thursday, July 10 in this episode of ...

Immune checkpoint inhibitors have changed the future of cancer care. These powerful treatments use the body’s own immune ...

A large-scale bibliometric analysis maps global research on hydrogels as next-generation drug delivery systems for cancer ...

Scientists at The Wistar Institute have discovered that a class of FDA-approved cancer drugs known as PARP1 inhibitors can ...

“Personalizing treatment in this way may lessen harmful side effects, reduce damage to healthy cells and make it more likely ...

Women in midlife face a difficult trade-off. Many in their 40s to 60s face a high risk of breast cancer, especially during ...

The anti-obesity medication tirzepatide, marketed as Mounjaro for diabetes and Zepbound for obesity, reduced ...

The deal also entails $1.23 billion in milestone payments. While Glenmark unit IGI will retain rights for India and emerging ...

A Financial District-based drug discovery company inked a $1 billion licensing agreement with pharmaceutical giant AbbVie to ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...